title: The nitroreductase system of inducible targeted ablation facilitates cell-specific regenerative studies in zebrafish.
abstract: At the turn of the 20th century, classical regenerative biology--the study of organismal/tissue/limb regeneration in animals such as crayfish, snails, and planaria--garnered much attention. However, scientific luminaries such as Thomas Hunt Morgan eventually turned to other fields after concluding that inquiries into regenerative mechanisms were largely intractable beyond observational intrigues. The field of regeneration has enjoyed a resurgence in research activity at the turn of the 21st century, in large part due to "the promise" of cultured stem cells regarding reparative therapeutic approaches. Additionally, genomics-based methods that allow sophisticated genetic/molecular manipulations to be carried out in nearly any species have extended organismal regenerative biology well beyond observational limits. Throughout its history, complex paradigms such as limb regeneration--involving multiple tissue/cell types, thus, potentially multiple stem cell subtypes--have predominated the regenerative biology field. Conversely, cellular regeneration--the replacement of specific cell types--has been studied from only a few perspectives (predominantly muscle and mechanosensory hair cells). Yet, many of the degenerative diseases that regenerative biology hopes to address involve the loss of individual cell types; thus, a primary emphasis of the embryonic/induced stem cell field is defining culture conditions which promote cell-specific differentiation. Here we will discuss recent methodological approaches that promote the study of cell-specific regeneration. Such paradigms can reveal how the differentiation of specific cell types and regenerative potential of discrete stem cell niches are regulated. In particular, we will focus on how the nitroreductase (NTR) system of inducible targeted cell ablation facilitates: (1) large-scale genetic and chemical screens for identifying factors that regulate regeneration and (2) in vivo time-lapse imaging experiments aimed at investigating regenerative processes more directly. Combining powerful screening and imaging technologies with targeted ablation systems can expand our understanding of how individual stem cell niches are regulated. The former approach promotes the development of therapies aimed at enhancing regenerative potentials in humans, the latter facilitates investigation of phenomena that are otherwise difficult to resolve, such as the role of cellular transdifferentiation or the innate immune system in regenerative paradigms.
authors.affiliation: Neuroscience Graduate Program, Georgia Health Sciences University, Augusta, GA 30912, USA.
authors.forename: David T
authors.initials: DT
authors.lastname: White
authors.forename: Jeff S
authors.initials: JS
authors.lastname: Mumm
mesh_terms: D000818:Animals; D001711:Biotransformation; D016923:Cell Death / Q000187:drug effects; D002454:Cell Differentiation; D049109:Cell Proliferation; D054338:Cell Transdifferentiation; D016503:Drug Delivery Systems / Q000379:methods; D029968:Escherichia coli Proteins / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008264:Macrophages / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008795:Metronidazole / Q000378:metabolism* / Q000494:pharmacology; D009601:Nitroreductases / Q000235:genetics* / Q000378:metabolism; D011355:Prodrugs / Q000378:metabolism* / Q000494:pharmacology; D012038:Regeneration / Q000502:physiology*; D017948:Retinal Rod Photoreceptor Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D059008:Time-Lapse Imaging; D019076:Transgenes; D015027:Zebrafish / Q000502:physiology*
chemical_list: D029968:Escherichia coli Proteins; D011355:Prodrugs; D008795:Metronidazole; C116053:NfsA protein, E coli; D009601:Nitroreductases
keywords: Ablation; Nitroreductase; Regeneration; Retina; Stem cells; Time-lapse; Zebrafish
references.citation: Science. 2002 Dec 13;298(5601):2188-90
references.pmid: 12481136
references.citation: J Biochem. 1996 Oct;120(4):736-44
references.pmid: 8947835
references.citation: Nat Biotechnol. 2001 Jun;19(6):579-82
references.pmid: 11385465
references.citation: Mech Dev. 2007 Mar;124(3):218-29
references.pmid: 17223324
references.citation: J Biol Chem. 2012 Jul 20;287(30):25353-60
references.pmid: 22573321
references.citation: J Assoc Res Otolaryngol. 2003 Jun;4(2):219-34
references.pmid: 12943374
references.citation: PLoS Genet. 2009 Apr;5(4):e1000455
references.pmid: 19381250
references.citation: Neural Dev. 2008 Apr 28;3:11
references.pmid: 18442390
references.citation: Mar Biotechnol (NY). 2010 Oct;12(5):569-78
references.pmid: 19941022
references.citation: Development. 2011 Aug;138(16):3421-30
references.pmid: 21752928
references.citation: PLoS One. 2012;7(7):e40508
references.pmid: 22815753
references.citation: Diabetes. 2000 Feb;49(2):157-62
references.pmid: 10868930
references.citation: Genetics. 2009 Jul;182(3):747-55
references.pmid: 19433629
references.citation: Cancer Gene Ther. 2005 Jul;12(7):627-39
references.pmid: 15746943
references.citation: Mech Dev. 1999 Feb;80(2):153-8
references.pmid: 10072782
references.citation: Dev Biol. 2001 May 15;233(2):329-46
references.pmid: 11336499
references.citation: J Vis Exp. 2011 Aug 29;(54):
references.pmid: 21897358
references.citation: Curr Pharm Des. 2007;13(1):119-26
references.pmid: 17266591
references.citation: Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2115-24
references.pmid: 11481280
references.citation: Eur J Cancer. 1995 Dec;31A(13-14):2362-70
references.pmid: 8652270
references.citation: Comp Med. 2007 Jun;57(3):241-6
references.pmid: 17605338
references.citation: Genesis. 2008 Oct;46(10):530-6
references.pmid: 18802959
references.citation: PLoS One. 2012;7(1):e29916
references.pmid: 22238673
references.citation: Neuron. 2006 Nov 22;52(4):609-21
references.pmid: 17114046
references.citation: Dev Neurobiol. 2007 Apr;67(5):637-54
references.pmid: 17443814
references.citation: Vision Res. 2002 Feb;42(3):293-9
references.pmid: 11809482
references.citation: J Comp Neurol. 2010 Mar 15;518(6):800-14
references.pmid: 20058308
references.citation: Proc Natl Acad Sci U S A. 2004 May 11;101(19):7369-74
references.pmid: 15123839
references.citation: Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3330-6
references.pmid: 15326158
references.citation: Blood. 2011 Jan 27;117(4):e49-56
references.pmid: 21084707
references.citation: Dev Neurobiol. 2007 Jul;67(8):1009-31
references.pmid: 17565703
references.citation: Dev Biol. 2007 Apr 15;304(2):811-24
references.pmid: 17335798
references.citation: Chem Senses. 2010 Jun;35(5):351-61
references.pmid: 20228140
references.citation: Biochem Pharmacol. 1988 Dec 15;37(24):4661-9
references.pmid: 3202902
references.citation: Dev Dyn. 2011 Aug;240(8):1929-37
references.pmid: 21761478
references.citation: Thromb Haemost. 2011 May;105(5):811-9
references.pmid: 21225092
references.citation: BMC Dev Biol. 2010 Nov 02;10:110
references.pmid: 21040591
references.citation: J Neurosci. 2003 May 1;23(9):3726-34
references.pmid: 12736343
references.citation: J Neurosci. 2012 Mar 7;32(10):3516-28
references.pmid: 22399774
references.citation: Cell Metab. 2012 Jun 6;15(6):885-94
references.pmid: 22608007
references.citation: J Vis Exp. 2010 Sep 20;(43):
references.pmid: 20972390
references.citation: Zebrafish. 2010 Mar;7(1):3-11
references.pmid: 20192852
references.citation: PLoS One. 2011;6(5):e20654
references.pmid: 21655190
references.citation: Cancer Gene Ther. 2011 Nov;18(11):773-84
references.pmid: 21836632
references.citation: Mar Biotechnol (NY). 2010 Aug;12(4):466-78
references.pmid: 19936986
references.citation: Chemosphere. 2004 Aug;56(7):659-66
references.pmid: 15234162
references.citation: Am J Anat. 1962 May;110:203-15
references.pmid: 13907765
references.citation: Diabetes. 2009 Aug;58(8):1844-51
references.pmid: 19491207
references.citation: Exp Cell Res. 2006 May 15;312(9):1526-39
references.pmid: 16490192
references.citation: Dev Dyn. 2004 Nov;231(3):527-41
references.pmid: 15376328
references.citation: BMC Genomics. 2009 Oct 16;10:477
references.pmid: 19832998
references.citation: Dev Biol. 2003 Dec 1;264(1):263-74
references.pmid: 14623247
references.citation: J Am Soc Nephrol. 2012 Jun;23(6):1039-47
references.pmid: 22440901
references.citation: BMC Neurosci. 2009 Aug 27;10:107
references.pmid: 19712466
references.citation: J Neurosci. 2012 May 30;32(22):7477-92
references.pmid: 22649227
references.citation: Nat Neurosci. 2010 Nov;13(11):1354-6
references.pmid: 20935642
references.citation: Development. 2006 Sep;133(18):3563-73
references.pmid: 16914496
references.citation: Dev Dyn. 2007 Apr;236(4):1025-35
references.pmid: 17326133
references.citation: FASEB J. 2010 Nov;24(11):4336-42
references.pmid: 20601526
references.citation: J Neurobiol. 2000 Sep 5;44(3):289-307
references.pmid: 10942883
references.citation: PLoS Genet. 2007 Jun;3(6):e88
references.pmid: 17542649
references.citation: Development. 2012 Oct;139(20):3838-48
references.pmid: 22951640